Advertisement

Product › Details
topoisomerase inhibitor
![]() |
Next higher product group | cancer drug |
![]() |
Status | 1996-01-01 registration start |
Status | 1997-01-01 sales existent | |
![]() |
Organisation | Pharmacia & Upjohn (Group) |
Group | Pfizer (Group) | |
Record changed: 2024-07-14 |
Advertisement

More documents for cancer drug
- [1] Tubulis GmbH. (2/6/25). "Press Release: Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.". Munich....
- [2] Tubulis GmbH. (1/30/25). "Press Release: Tubulis Announces First Patient Dosed in Phase I/IIa Trial Evaluating ADC TUB-030 in Advanced Solid Tumors". Munich....
- [3] Coulter Partners. (1/23/25). "Press Release: Coulter Partners Secures CEO Placement for NeoPhore"....
- [4] ITM Isotope Technologies Munich SE. (1/16/25). "Press Release: Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO". Chalk River, ON....
- [5] Biosaxony e. V.. (1/16/25). "Press Release: Radiation Made in Saxony – Saxon Radiopharmacy Network nukliD Strengthens International Visibility"....
- [6] Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin....
- [7] BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg....
- [8] GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London....
- [9] ITM Isotope Technologies Munich SE. (1/13/25). "Press Release: ITM and Ariceum Therapeutics Enter into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225". Garching, Munich & Berlin....
- [10] Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top